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Recently, we have reported the isolation of cDNAs encoding the precursors of insulin-like growth factors 
I and II (IGF-I and II) [(1983) Nature 306, 609-611; (1985) FEBS Lett. 179, 243-246. These cDNAs were 
employed as specific probes to detect and isolate the corresponding genes from human cosmid DNA librar- 
ies. Three cosmids were detected, together containing the entire cDNA sequence of IGF-I, and one cosmid 
containing the sequence of IGF-II cDNA. Southern blot hybridization, physical mapping and nucleotide 
sequence analysis of these cosmids revealed that the IGF-I and -11 genes have a discontinous structure. The 
IGF-I gene contains at least four exons spanning a region of probably more that 45 kilobasepairs (kb), 
while the IGF-II gene consists of at least five exons, spanning a region of 16 kb. 
Insulin-like growth factor I Insulin-like growth factor II 
1. INTRODUCTION 
The insulin-like growth factors (IGF) constitute 
a heterogeneous group of hormonal polypeptides 
with insulin-like and growth-promoting properties. 
The amino acid sequence of 2 of the human IGFs 
have been identified [3,4]. IGF-I consists of 70 
amino acids, while IGF-II, which is composed of 
67 amino acids, shares homology with the so-called 
multiplication stimulating activity (MSA) in the rat 
[5]. Both IGF-I and IGF-II show a high degree of 
homology. 
We have reported the sequences of cDNAs en- 
coding human IGF-I and IGF-II [1,2]. These se- 
quences reveal that the coding regions of IGF-I 
and IGF-II are flanked by regions encoding amino- 
terminal as well as carboxyl-terminal peptides, in- 
dicating that both growth factors are synthesized 
as precursor molecules. The nucleotide sequence of 
human IGF-II cDNA was also determined by Bell 
et al. [6]. 
Somatomedin Gene structure Hormone precursor 
Using the cDNAs as specific probes, the 
chromosomal assignment has been determined. 
The IGF-I gene maps to chromosome 12, whereas 
the gene for IGF-II is located on chromosome 11 
[7-lo]. Here, we report the genomic organization 
of the coding and the flanking non-coding regions 
of the human IGF-I and IGF-II genes. 
2. MATERIALS AND METHODS 
2.1. Genomic libraries 
Two non-amplified human genomic cosmid 
libraries were constructed from human placenta 
DNA as described [ 111. A third cosmid genomic 
library was constructed from GM 1416,48 XXXX 
cell-line DNA, using a double-cos-site vector 2cRB 
[12]. Cosmids were transduced into E. coli 1046 
and of each library 200000 colonies were screened 
basically as described by Benton and Davis [13]. 
Nitrocellulose filter (90 mm, Satorius), containing 
20000 colonies each, were washed after hybridiza- 
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tion under stringent conditions (0.3 x SSC, 0.1% 
SDS, pH 7.4) at 65°C. 
2.2. DNA probes 
cDNA probes were isolated from the plasmids 
pIGF-I, pIGF-II and pIGF-II var [1,2]. The 73 1 bp 
cDNA probe of IGF-I consists of the coding region 
of the IGF-I precursor, flanked by the 5’- and 
3 ‘-non-translated regions of 80 and 264 bp, 
respectively. As probes for IGF-II we used partial- 
ly overlapping cDNAs containing the coding 
regions of the IGF-II precursor, flanked by 5 ’ - and 
3 ‘-non-translated regions of 488 and 237 bp, 
respectively. Double-stranded cDNA probes were 
labeled by nick-translation with [a-32P]dCTP to a 
specificity of lo* cpm/pg DNA. 
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. ..TCTGTGT TTTGTAGATA A4TGTGAGGA TTTTCTCTAA ATCCCTCTTC TGTTTGCTAA ATCTCACTGT CACTGCTAAA TTCAGAGCAG ATAGAGCCCG 
0 ~Gc~T~ T~GTCCTC AA~TTG~ TGTGACATTG CTCTC~AT CTCCCATCTC TCT~TTCT TTT~TTCAT TATTCCTGCT ~CC~rT~A -I J -80 -70 -60 -50 -*o -30 -20 -10 
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ThC Ala Gly Pro Glu Thr Iso Cys Gly Ala Cl‘, teu Val Asp Ala Lcu Gin Pk Val Cys Cly ASD Ary Gly Phe Tyr Phe A 
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. . . TTG ATT TGT GCA & AAG CCC iCA GGG TAT Gk TCC AGC AGi CGG AGG GCG iCT CAG ACA &T ATC GTG GAT GAG TGC TGC iTC CGG 
sn Lys Pro Thr Gly Tyr Gly Ser Ser Ser Arg Arg Ala Pro GLn Thr Gly Ile Val ASD Glu Cys Cys Phe Arg 
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2 AGc T&T GAT CTA AGE. AGG CTG GAG ATG TAT TGC G6A ccc CTC mE, CCT GCC AAG ~CA GCT cGc TET GTC CGT GCE. CAG cGc cAc kc GAc Ser Cgs Asp Leu Arg Arq UN, Glu Met Tyr Cys Ala Pro Leu Lys Pro Al.3 Lys Ser Ala Arg Ser Val Arq Ala Gin Arg Us Thr AsD 
120 I!0 
ATG CiC AAG ACC CAG AAG'GTA AGC CCA CCT . . . 
Met Pro Lys Thr Gin Lys 
V or0 350 365 370 180 190 rC2 
. . . CTT TAT TTA TAG wu\ GTA EAT TTG GAG AA; GCA AGT Ed GGG AGT GCA QA AAC MG AAC TAC AGG AT& TAG GAA GAC &T CCT GAG 
Glu Val His Leu Lyn Am Ala Ser Arg Gly Ser Ala Gly Am Lys Am Tyr Arg Met -- 
*1* *a0 *3* u*P ‘150 rho -79 *8b *9c 
GAG TGA AGA GTEt ACA TGC CAC EGC AGG ATC CTi TGC TCT GCi\ CGA GTT ACC iGT TAA ACT TiG GAA CAC CTi CCA AAA AAT iAG TTT GAT 
0 3 590 510 520 530 SC0 551 560 570 
580 
Ak ATT TAA AA& ATG GGC GTT iCC CCC AAT GA ATA CM A,& TAA ACA TTC hA CAT TGT CiT TAG GAG TGA TTT GCA CCT +GC AAA AAT 
590 6.00 6!O 620 610 6?0 650 
G;;T CCT GGA GTT GGT AGA TTG CTG TTG ATC TT; TAT CAA Tti TGT TCT ATA GM AAG MA Ah AAC ACA CAC ACA CAC ACA CAC TTA GTC 
CTG ‘ICC TAG . . . . . . 
Fig.1. Nucleotide sequence of the human IGF-I g:ne. Th& numbers - 1, 1, 2 and 3 refer to the corresponding exons. 
The exon-intron boundaries are indicated by v ; v and v are the 2 possible 5 ‘-splice sites of exon - 1. Starting with 
the ATG codon for initiation of translation the sequence corresponding to the cDNA is numbered positive in the 
5 ’ -+3 ’ direction and negative in the 3 ’ -5’ direction. The prepro-IGF-I amino acid sequence is shown, in which 
the underlined part indicates the mature IGF-I peptide. 
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2.3. Southern blotting of cosmid DNA 
Cosmid DNA was isolated according to stan- 
dard procedures [ 141. 1 pg cosmid DNA was 
digested with several restriction enzymes, run on 
an 0.7% agarose gel and transferred to 
nitrocellulose (Schleicher and Schtill). Hybridiza- 
tions were performed in the presence of 50% for- 
mamide at 42°C (18 h). Blots were washed under 
stringent conditions at 65”C, 1 x SSC, 0.1% SDS, 
pH 7.4. 
2.4. Restriction mapping, subcloning and 
nucleotide sequence analysis 
The cosmid clones containing parts of the 
human IGF-I or IGF-II genes were purified. After 
restriction enzyme analysis, fragments carrying the 
human IGF-I or IGF-II sequences were identified 
by Southern blot hybridization. Using [cu-~*P] 
dCTP specific cDNA probes restriction maps of 
these cosmids were constructed. Some cosmid 
fragments were isolated directly, other fragments 
were first subcloned in pUC12 followed by se- 
quence analysis. Nucleotide sequence analysis was 
carried out according to Maxam and Gilbert [ 151. 
3. RESULTS 
Employing 32P-labeled cDNA probes encoding 
IGF-I and IGF-II, respectively, 3 human genomic 
cosmid DNA libraries were screened for IGF-I and 
-11 specific clones as described in section 2. Three 
different clones (clones a, b and c) hybridized 
specifically with IGF-I cDNA, whereas only a 
single clone showing homology to IGF-II cDNA 
was isolated (cos IGF-II). 
Southern blot hybridization analysis of IlindIII- 
digested total human placenta DNA and the 
above-mentioned cosmid DNAs revealed that the 
entire IGF-I and IGF-II cDNA sequences were pre- 
sent in these 4 cosmids (not shown). Employing 
detailed restriction enzyme analysis, Southern blot 
hybridization and nucleotide sequence analysis of 
the cosmids, we have determined the precise posi- 
tion of the IGF-I and IGF-II specific sequences on 
the physical maps of the cosmids described above 
(figs l-3). This analysis reveals that the genes 
coding for IGF-I and IGF-II have a discontinuous 
structure. The 713 bp IGF-I cDNA is encoded by 
4 exons extended over at least 45 kb of genomic 
DNA, while the 1265 bp IGF-II cDNA sequence is 
encoded by 5 exons spanning a region of 16 kb of 
chromosomal DNA. 
4. DISCUSSION 
We have studied the organization of the genes 
coding for human IGF-I and IGF-II. Employing 
Southern blot hybridization and nucleotide se- 
quence analysis the IGF-I and IGF-II cDNAs con- 
taining the entire coding sequence for the precur- 
sor as well as the 5 ‘- and 3 ‘-non-coding sequences 
have been positioned on genomic cosmid clones. 
Comparison of the structure of the exons of the 
IGF-I and IGF-II genes shows some interesting 
common features. Both genes contain an exon (ex- 
on 1) which starts 6 bp in front of the potential 
ATG initiation codon and terminates close to the 
COOH-terminus of the B-domain. Also, both 
genes contain an exon starting at the end of the B- 
domain and terminating in the E peptide of the 
growth factor precursors (exon 2), while in both 
genes the COOH-termini of the precursor are 
located in a single exon (exon 3, fig.3). On the 
other hand, the size of the corresponding introns 
seems to differ extensively. The gene for IGF-I 
must be of considerable length since the 713 bp 
cDNA is divided over 4 exons which are located on 
3 non-overlapping cosmid DNAs, suggesting that 
these exons are located on a stretch of human 
chromosomal DNA of at least 45 kb. Although 
our cosmid clones contain the entire coding region 
of the IGF-I precursor they probably do not repre- 
sent the entire IGF-I mRNA, because the cDNA 
appears to be incomplete. The previously assigned 
poly(A) tail [l] is also present in genomic DNA in- 
dicating that this A-rich region in IGF-I cDNA 
does not represent he actual poly(A) tail. 
The gene for human IGF-II spans a region of at 
least 16 kb chromosomal DNA. The positions of 
exons 1,2 and 3 have also been determined by Dull 
et al. [ 171, who used a rat MS cDNA as probe. As 
described in [2], 2 closely related but distinct types 
of IGF-II cDNA were isolated from the same 
human liver cDNA library. The difference of the 
IGF-II variant (IGF-II var) compared to IGF-II is 
situated at amino acid 29, where the variant IGF-II 
cDNA predicts a tetrapeptide Arg-Leu-Pro-Gly 
due to an insert of 9 nucleotides at position 158 
(fig.2). Interestingly, examination of the genomic 
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TGCTTTGGTG GTGACTGCTA ATATTGGCCA GGCCGGCGGA TCATCGTCCA GGCAGYTTCG GCAGAGAGCC TTGGGCACCA GTGACTCCCC‘ 
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. ..TTTGTTT TTCC CCGAAGAGTC ACCACCGAGC CTGTGTGGGA GGAGGTGGAT TCCAGiCCCC AGCCCiAffiG CTCTGiATCG 
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CTGCC.kClC AGCcCiCTGC CCAGChGCC cCACAiCCTG AGCCCiGGCA SCALD CCCAGiCCTG ~T~TG CTGTGiCCTG 
TCsCCw GACCCC&CC cTCLCAGA&C TGAGGCTGGC AGCCAGCCCC AGCCTCAGCC CCAACTGCGA GGCAGA TGAGTGTCTC 
AWLA..... 
13 ‘3 10 *o 10 ho 
. . . TCC CGC CCC CAG%A CCA ATG GGA ATC &A ATG GGG AiG TCG ATG CT6 GTG CTT CTC iCC TTC TTG GiC TTC GCC TCi TGC TGC ATT 
llet ClY Jk fV3 M-X (;Iy I.yza S*.I Met b-u V&i Leo Lvu Thz Pfw Leu Ala Phe Ala Ser C,,s cys I& 
0 
70 80 PJ 1 LOI) 110 ,!J 110 1*0 150 iCT GCT TM &C Ccc AGT u\i; KC CTG TGC iGC GGG GAG CiG GTG GAC ACC CTC CAG TTC iTC TGT GGG GiC CGC GGC TTi TAC TTC x T 
Ala AAd Tyr Arg Pro Ser Glu Tht Leu Cys Cly Gly G14 L+?u Val ASP Thr Leu Gin Phe Val Cys Gly Asp Arg Gly Phe Tyr Phe S 
A 
A& TMi CtG 66A 666 . . . . . . 
. . . CTC TGT GCT GTG AGG CCC GCA AGC CGT GTG AGC CGT CCC AGC CGT GGC ATC GTT GAG GAG TGC TGT TTC CGC AGC 
er 1~ Pro Ale Ser Arg Val Ser Arg Arg Ser Arg Gly Ile Val Clu Clu Cys Cys Phr, tig Ser 
0 
ff,“” Pro oy:50 z 
2 
I1P :s* 170 I80 293 100 
TGT ixc ci6 Gee CTC CT; witi Asi TAC ~GT GCT Act tie GCC iw TCE GAG Au; GAc GTG TCG Act ch CCG ACC GTG CTT CCGIGTG AGG 
Cys &p &eu Ala lm La, Clu Tlu Tyr Cgs Ala Thr Pro Ala Lys .Q’r Ciu Arg As&z Val Ser Ths Pro Pm Thr Val Leu Pro 
GTC CT6 GGC . . . . . . 
IIJ 3, I 3.0 IV 
. . . . . . ccc Ttt ccc Tee m%C k TTc ccc Ak TAc ccc G~'IGGc AAc TTc ire cAA TAT CL ACC TGG AZ'CAG TCC ACC'LG CGC 
&p Asn Phe Pro Ary Tys Pro Vai Gly Lys pha Phe Gin Tyr Asp Thr’ Trp Lys Gln Ser Thr Gin Arg 
sL1* 394 U‘ 8 *io **it *51) 
CTG Ck &G GGC CTi CCT GCC CTC"hG CGT GCC CiC CCC GGT CAi GTG CTC GCC%G GAG CTC GiG GCG TTC AGi GAG GCC AAA*%T CAC 
lhu Arg AW ClY .WU Pro Ala LeU Leu ACT Ala Ary AW.I Cfy His Val Leu Ala Lys GJu Leu Gtu Ala Phe A19 Glu Ala Lys Arg His 
*70 IbO “10 ‘8 0 ii 510 ,LO ! 1: 110 550 
CGT CiC CTG ATT GCi CTA CCC ACC hA GAC CCC GiC CAC GGG GbC CCC CCC CCA iAG ATG GCC A& AAT CGG AAii TGA GCA AM tTG CCG 
AZT Pro &u Ile Ala Leu Pm Thr GJn Asp Pro Ala His Cly Cly Ala Pro Pro Glu Net Ala Ser Am Ar‘g Lyo --- 
0 3 
560 110 ,80 51” 6 0 4 3. i u c ‘1 610 6bO 
CM GiC TGC AGC C& GCG CCA CCA iCC TGC AGE CiC CTC CTG A& ACG GAC GTT iCC ATC AGG T+C CAT CCC GAi AAT CTC YCG E;iT CCA 
hSC 6 ‘ 0 61'3 ‘"3 f.10 701 TiO 710 -,* 
CGT Ck CTG GGG CT; CTC CTG ACC SAG TCC CCC Tk CCC CCC TtC CC6 AAA CAG iCT ACT CTC CiC GGC CCC CTi CAT CGG GCT iiAG GM 
7*0 750 760 710 78" 
GCA CiG CAG CAT CTi CM ACA TGT kA AAA TCG Aif GGC TTT AiA CAC CCT TCA CAT ACC CTC CCC CCA AAT TAT CCC CAA TTA TCC CCA 
CAC ATA MA MT CAA AAC ATT AAA CTA ACE CCC TTC CCC CCC CCC CAC AAC AAC CCT CTT AAA ACT AAT TGG CTT TTT AGA AAC ACC CCA 
CAA AAG CTC A&4 AAT TGG CTT TAA AAA AM CAA CCA CCA AAA AAA ATC AAT TGG CTA AAA AAA AAG CAC CAA AAA CGA CCG GCT GAG AAC 
AAT CGC . . . . . . 
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Fig.2. Nucleotide sequence of the human IGF-II gene. The numbers - 2, - 1, 1, 2 and 3 refer to the corresponding 
exons. The 5’- and 3’-exon-intron boundaries are indicated by (v). Starting with the ATG codon for initiation of 
translation the sequence co~esponding to the cDNA is numbered positive in the 5 ’ -3 ’ direction and negative in the 
3 ‘-5 ’ direction. The prepro-IGF-II amino acid sequence is shown as well as the 3 amino acid insert for IGF-II var. 
The underlined amino acid sequence indicates the mature IGF-II peptide. A possible alternative poly(A) site ATTAAA 
is also underlined. 
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Fig.3. Schematic representation of the IGF-I and IGF-II genes. The cDNA structures containing regions coding for the 
B, C, A and D domains (higher open boxes), the N-terminal peptide (pre), the C-terminai peptide (E) and the 5’- and 
3’4mtranslated sequences are schemati~lly depicted. The restriction maps of the genomic cosmid clones, a, b and c 
for IGF-I and cosIGF-II and the localization of the exons are indicated. The exons are shown by the black boxes 
numbered negative for the S’non-coding regions and positive for the coding regions. The exon carrying the ATG 
initiation codon of the signal peptide is designated exon 1. Starting with the ATG codon for initiation of translation, 
the sequence corresponding to the cDNA is numbered positive in the 5 ’ -3’ direction and negative in the 3’-+5’ 
direction. The 5 ‘-end of exon - 1 of the IGF-I gene is indicated by 2 potential acceptor splice sites ( 6 and 8 , fig, 1). 
The non~ucl~tide insert in the B-domain of IGF-II var cDNA is indicated by the shaded block. Restriction sites: *, 
HindIII; v, EcoRI; 0, &rrtHI; 0, KjrnI. 
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DNA sequence reveals that the difference is 
located at the 5 ’ -intron-exon boundary of exon 2. 
At this position IGF-II var contains a 
nonanucleotide insertion which is identical to the 
last 9 bp of the intron for IGF-II cDNA (fig.2, ex- 
on 2). This suggests that the corresponding IGF-II 
var mRNA arises by splicing 9 nucleotides 
upstream from the acceptor splice junction of IGF- 
II (fig.2, exon 2). However, the nucleotide se- 
quence at the hypothetical IGF-II var intron-exon 
junction of exon 2 (CTGTG_G) deviates from the 
canonical acceptor sequence PyPyNPyAG [ 181. 
Furthermore, Atweh et al. [19] have demonstrated 
that the sequence CCACGG is not functional in 
splicing. At the moment we favour the explanation 
that the IGF-II var gene represents an allelic 
variant of the IGF-II gene containing the acceptor 
sequence CTGTAG which is present in the human 
population in low abundance. Interestingly, the 
IGF-II var gene is expressed in vivo, since recently 
Humbel has identified its gene product as a minor 
fraction in pooled sera (Humbel, personal com- 
munication). Also, for IGF-II it is unlikely that the 
cDNAs obtained so far represent the complete 
messenger RNA, since a polyadenylation signal 
and a poly(A) tail are absent in the cDNAs. In this 
respect it is noteworthy that Scott et al. [20] recent- 
ly demonstrated by Northern blot analysis of total 
RNA from adult human liver that IGF-II mRNA 
has a length of 5.3 kb. Further studies of the 
genomic cosmic clones and isolation of longer 
cDNAs will be necessary to determine additional 
5 ’ - and 3 ’ -non-translated exons. 
In conclusion, we have identified at the 
nucleotide level those parts of the IGF-I and IGF- 
II genes which correspond to the coding sequences 
of prepro-IGF-I and -11. The results obtained so 
far. suggest hat the IGF-I and -11 genes contain 
long non-coding sequences, spanning an extensive 
region of the human genome. 
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